360 NEWS360 NEWS

Business ยท National

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.ย 

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œModerna raises 2026 outlook as CEO says newer vaccines are gaining tractionโ€?

This is self-selected reader participation, not representative scientific polling.